Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients
Authors:
- Camila Miranda Lopes-RamosCLCamila Miranda Lopes-Ramos
- Angelita Habr-GamaAHAngelita Habr-Gama
- Bruna de Souza QuevedoBQBruna de Souza Quevedo
- Natália Mariana FelícioNFNatália Mariana Felício
- Fabiana BettoniFBFabiana Bettoni
- Fernanda Christtanini KoyamaFKFernanda Christtanini Koyama
- Paula Fontes AsprinoPAPaula Fontes Asprino
- Pedro Alexandre GalantePedro Alexandre Galante
- Anamaria Aranha CamargoACAnamaria Aranha Camargo
- Rodrigo Oliva PerezRPRodrigo Oliva Perez
Open Access
- 11 December 2014
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 7 (1) , 68
Abstract
Neoadjuvant chemoradiotherapy (nCRT) followed by radical surgery is the preferred treatment strategy for locally advanced rectal cancer. However, complete tumor regression is observed in a significant proportion of patients after nCRT, making them ideal candidates for alternative treatment strategies to this considerably morbid procedure. Identification of such patients based on clinical findings (complete clinical response - cCR) is difficult mainly because it relies on subjective clinical and imaging studies. Our goal was to identify biomarkers capable of predicting complete response to nCRT. We analyzed miRNA expression profile using deep sequencing in rectal tumor biopsies prior to nCRT. Differential expression was investigated by EdgeR for a training (n = 27) and a validation (n = 16) set of patients to identify miRNAs associated with treatment response (complete vs. incomplete). In vitro experiments with two cancer cell lines were also performed in order to evaluate the possible role of miRNAs on response to nCRT. We found 4 miRNAs differentially expressed between complete and incomplete responders to nCRT. In addition, validation was performed using an independent group of patients and miR-21-5p was confirmed as being overexpressed in complete responders. Overall sensitivity and specificity of miR-21-5p expression in predicting complete response to nCRT was 78% and 86% respectively. Interestingly, in a subset of patients with cCR followed by early local recurrence, the expression level of miR-21-5p was considerably low, similarly to incomplete responders. We also found SATB1, a miR-21-5p target gene and known multidrug resistance gene, whose expression was inversely correlated with miR-21-5p expression. Finally, we performed functional experiments and showed that miR-21-5p and SATB1 may be directly involved with poor response to nCRT in rectal cancer patients. This study suggests miR-21-5p as a promising predictive biomarker, which should aid in the selection of patients with cCR to nCRT that potentially could be spared from radical surgery.Keywords
This publication has 55 references indexed in Scilit:
- Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationNature Immunology, 2011
- MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)Proceedings of the National Academy of Sciences, 2010
- miRBase: integrating microRNA annotation and deep-sequencing dataNucleic Acids Research, 2010
- MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cellsBritish Journal of Cancer, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001